Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 107451-107500 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT03476681
Study of NEO-201 in Solid Tumors Expansion Cohorts
PHASE1/PHASE2
Recruiting
121 participants
Started: Jan 18, 2019 · Completed: Jan 15, 2029
4 conditions
1 sponsor
2 locations
NCT03853356
Evidence For Fusion In Spine With Orthoss®
N/A
Active, not recruiting
65 participants
Started: Jan 18, 2019 · Completed: Jan 31, 2027
4 conditions
1 sponsor
3 locations
NCT03748069
Influenza Associated Aspergillosis In-depth Investigation
N/A
Recruiting
45 participants
Started: Jan 18, 2019 · Completed: Apr 30, 2025
2 conditions
1 sponsor
1 location
NCT03785288
Vaginal Cuff Brachytherapy Fractionation Study
PHASE3
Recruiting
258 participants
Started: Jan 17, 2019 · Completed: Jan 1, 2026
1 condition
1 sponsor
3 locations
NCT03725956
Polysomnographic Findings in Nasal Polyposis
NA
Recruiting
30 participants
Started: Jan 17, 2019 · Completed: Dec 31, 2023
2 conditions
1 sponsor
1 location
NCT03746431
A Phase 1 Study of [225Ac]-FPI-1434 Injection
PHASE1/PHASE2
Recruiting
253 participants
Started: Jan 17, 2019 · Completed: Jun 30, 2026
10 conditions
1 sponsor
13 locations
NCT03810807
Study of Dacomitinib and Osimertinib for Patients With Advanced EGFR Mutant Lung Cancer
PHASE1
Active, not recruiting
22 participants
Started: Jan 17, 2019 · Completed: Jan 31, 2026
1 condition
1 sponsor
7 locations
NCT03428373
Rivaroxaban or Aspirin As Thromboprophylaxis in Multiple Myeloma
PHASE2/PHASE3
Active, not recruiting
57 participants
Started: Jan 17, 2019 · Completed: Sep 30, 2024
6 conditions
5 sponsors
1 location
NCT03243175
Avoiding Anticoagulation After IntraCerebral Haemorrhage
PHASE3
Recruiting
300 participants
Started: Jan 17, 2019 · Completed: Dec 31, 2028
3 conditions
3 sponsors
3 locations
NCT03809715
"Coroflex ISAR NEO All Comers Post Market Clinical Follow-up (PMCF)"
N/A
Active, not recruiting
3,520 participants
Started: Jan 17, 2019 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT03682289
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
PHASE2
Recruiting
89 participants
Started: Jan 17, 2019 · Completed: Mar 31, 2028
13 conditions
2 sponsors
3 locations
NCT03375788
Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk
PHASE2
Active, not recruiting
76 participants
Started: Jan 17, 2019 · Completed: Jan 10, 2025
5 conditions
1 sponsor
1 location
NCT04644224
Parent and Family Oriented Support Interventions for the Facilitation of Weight Loss in African American Families
NA
Active, not recruiting
81 participants
Started: Jan 17, 2019 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT03818412
Circulating Tumor DNA in Soft Tissue Sarcoma
NA
Recruiting
40 participants
Started: Jan 17, 2019 · Completed: Jan 17, 2025
1 condition
3 sponsors
1 location
NCT03763162
Daratumumab, Bortezomib, and Dexamethasone Followed by Daratumumab, Ixazomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
PHASE2
Active, not recruiting
40 participants
Started: Jan 17, 2019 · Completed: Oct 30, 2025
2 conditions
2 sponsors
1 location
NCT03799835
Atezolizumab Plus One-year BCG Bladder Instillation in BCG-naive High-risk Non-muscle Invasive Bladder Cancer Patients
PHASE3
Active, not recruiting
517 participants
Started: Jan 17, 2019 · Completed: Oct 31, 2028
1 condition
2 sponsors
38 locations
NCT03786549
Pediatric -Adult Care Transition Program of Patients With Sickle Cell Disease
NA
Recruiting
196 participants
Started: Jan 16, 2019 · Completed: Apr 16, 2027
1 condition
1 sponsor
8 locations
NCT03808662
Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung
PHASE2
Active, not recruiting
107 participants
Started: Jan 16, 2019 · Completed: Jan 31, 2026
7 conditions
1 sponsor
10 locations
NCT03827876
Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis
PHASE4
Recruiting
30 participants
Started: Jan 16, 2019 · Completed: Dec 15, 2019
1 condition
2 sponsors
1 location
NCT04139499
Use of High-resolution Manometry to Detect Upper Airway Obstruction During Sleep
N/A
Recruiting
172 participants
Started: Jan 16, 2019 · Completed: Jan 31, 2026
1 condition
1 sponsor
1 location
NCT03589339
NBTXR3 Activated by Radiotherapy for Patients with Advanced Cancers Treated with an Anti-PD-1 Therapy
PHASE1
Recruiting
145 participants
Started: Jan 16, 2019 · Completed: May 30, 2028
11 conditions
1 sponsor
13 locations
NCT03696680
Stereotactic Radiotherapy for Cerebral Metastases with Recent Hemorrhagic Signal
PHASE2
Recruiting
46 participants
Started: Jan 16, 2019 · Completed: Jan 31, 2028
1 condition
3 sponsors
4 locations
NCT03914391
To Identify Potential New Urine Markers for the Screening of Prostate Cancer
N/A
Recruiting
10,000 participants
Started: Jan 16, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03808337
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
PHASE2
Recruiting
145 participants
Started: Jan 16, 2019 · Completed: Jan 31, 2026
4 conditions
1 sponsor
12 locations
NCT03817268
Capecitabine or Observation for Patients With pT1N+M0 or pT2-3N0M0 Gastric Adenocarcinoma Undergoing R0 Resection
PHASE3
Recruiting
768 participants
Started: Jan 16, 2019 · Completed: Jan 30, 2026
1 condition
1 sponsor
1 location
NCT06716866
Temporally Interfering Electric Field Stimulation in the Treatment of Epilepsy
NA
Enrolling by invitation
100 participants
Started: Jan 16, 2019 · Completed: Jul 31, 2030
1 condition
5 sponsors
3 locations
NCT03771859
A Study of Patients Receiving Adjuvant Nivolumab Therapy for Melanoma That Has Been Removed
N/A
Active, not recruiting
152 participants
Started: Jan 16, 2019 · Completed: Dec 30, 2025
1 condition
1 sponsor
14 locations
NCT03360552
Evaluating the Effectiveness of a New Way of Organizing Primary Health Care to Improve the Management of Alzheimer's Disease
NA
Recruiting
320 participants
Started: Jan 16, 2019 · Completed: Jan 15, 2026
1 condition
1 sponsor
1 location
NCT04541693
REDAPT Revision Hip System With RSA
NA
Active, not recruiting
8 participants
Started: Jan 15, 2019 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT04381611
INTEGRAL Study: A Longitudinal Study of Surgeries and Lasers in Glaucoma: Long-term Results and Success Predictors Analysed From a Large-scale Retrospective and Prospective Glaucoma Register
N/A
Enrolling by invitation
30,000 participants
Started: Jan 15, 2019 · Completed: Jan 15, 2030
10 conditions
1 sponsor
1 location
NCT03757091
Flexible Intubation Scope With or Without Video Laryngoscope in Supporting Endotracheal Tube Placement in Patients With Head and Neck Cancer Before Surgery
NA
Recruiting
144 participants
Started: Jan 15, 2019 · Completed: Aug 31, 2025
1 condition
2 sponsors
1 location
NCT04258462
Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With Renal Tumors
PHASE2
Recruiting
100 participants
Started: Jan 15, 2019 · Completed: Dec 31, 2026
3 conditions
3 sponsors
1 location
NCT03758521
Natural History Study of Patients with Succinic Semialdehyde Dehydrogenase (SSADH) Deficiency
N/A
Active, not recruiting
55 participants
Started: Jan 15, 2019 · Completed: Jun 30, 2029
1 condition
5 sponsors
4 locations
NCT03183895
Evaluate the Safety and Performance of the AccuCinch® Ventricular Repair System - The CorCinch-EU Study
NA
Active, not recruiting
132 participants
Started: Jan 15, 2019 · Completed: Dec 31, 2027
2 conditions
1 sponsor
19 locations
NCT03662126
KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor Treatment
PHASE2/PHASE3
Recruiting
385 participants
Started: Jan 15, 2019 · Completed: Dec 31, 2025
3 conditions
1 sponsor
191 locations
NCT03865667
Post Market Clinical Follow-Up Study Protocol for PROFEMUR® Preserve Femoral Stem
N/A
Active, not recruiting
63 participants
Started: Jan 15, 2019 · Completed: Jan 1, 2032
1 condition
1 sponsor
1 location
NCT03846375
Emotional Dysregulation in Para-suicidal Behavior
NA
Recruiting
60 participants
Started: Jan 15, 2019 · Completed: Jan 2, 2028
4 conditions
2 sponsors
1 location
NCT04176523
Understanding the Long-Term Management of Organic Acidemia Patients With CARBAGLU®: A Mixed Methods Approach
N/A
Recruiting
95 participants
Started: Jan 15, 2019 · Completed: Jul 30, 2029
2 conditions
1 sponsor
32 locations
NCT03911531
Whole Exome Sequencing and Whole Genome Sequencing for Nonimmune Fetal/Neonatal Hydrops
N/A
Recruiting
55 participants
Started: Jan 15, 2019 · Completed: Dec 31, 2028
3 conditions
1 sponsor
1 location
NCT03756298
Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
PHASE2
Active, not recruiting
284 participants
Started: Jan 15, 2019 · Completed: Jan 31, 2027
1 condition
1 sponsor
1 location
NCT03873064
Body Mass Index (BMI) and Quality of Life (QoL) in Cancer Patients
N/A
Recruiting
1,380 participants
Started: Jan 15, 2019 · Completed: Jan 15, 2034
3 conditions
2 sponsors
1 location
NCT03385226
A Trial Assessing the Effect of Pembrolizumab Combined with Radiotherapy in Patients with Relapsed, Refractory, Specified Stages of Cutaneous T-cell Lymphoma (CTCL) Mycosis Fungoides (MF)/Sezary Syndrome (SS)
PHASE2
Active, not recruiting
46 participants
Started: Jan 15, 2019 · Completed: Sep 30, 2025
2 conditions
2 sponsors
11 locations
NCT03785249
Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1
PHASE1/PHASE2
Active, not recruiting
731 participants
Started: Jan 15, 2019 · Completed: Dec 31, 2026
3 conditions
1 sponsor
222 locations
NCT03783546
Acupuncture for Hot Flashes in Hormone Receptor-Positive Breast Cancer, a Randomized Controlled Trial
NA
Active, not recruiting
84 participants
Started: Jan 15, 2019 · Completed: Dec 1, 2025
1 condition
2 sponsors
1 location
NCT05447299
Neuromusculoskeletal Modeling of Muscle Spasticity
N/A
Enrolling by invitation
90 participants
Started: Jan 15, 2019 · Completed: Dec 30, 2030
5 conditions
4 sponsors
1 location
NCT03593759
Cardiac Sarcoidosis Randomized Trial
PHASE3
Recruiting
194 participants
Started: Jan 15, 2019 · Completed: Dec 31, 2025
2 conditions
2 sponsors
30 locations
NCT03812666
Search for Biomarkers of Infection and Inflammation in Patients With Acute Stroke.
N/A
Active, not recruiting
200 participants
Started: Jan 15, 2019 · Completed: Jul 1, 2025
2 conditions
2 sponsors
1 location
NCT03266393
Envarsus XR® in Adolescent Renal Transplant Recipients
PHASE4
Active, not recruiting
28 participants
Started: Jan 15, 2019 · Completed: Mar 31, 2023
3 conditions
2 sponsors
1 location
NCT02573896
Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells
PHASE1
Active, not recruiting
13 participants
Started: Jan 14, 2019 · Completed: Sep 30, 2025
1 condition
3 sponsors
11 locations
NCT03808077
The Effect of Deep Versus Moderate Muscle Relaxants in Men During and After Robotic Surgery for Prostate Cancer
PHASE2
Active, not recruiting
139 participants
Started: Jan 14, 2019 · Completed: Jan 31, 2026
1 condition
1 sponsor
1 location
Previous
1
More pages
2147
2148
2149
2150
2151
2152
2153
More pages
2369
Next